List view / Grid view


Roche purchases shares in tender offer for InterMune, Inc.

30 September 2014 | By Roche

Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash...

Pfizer completes acquisition of InnoPharma

26 September 2014 | By Pfizer

Pfizer Inc. announced that it has completed its acquisition of the pharmaceutical development company, InnoPharma, Inc., following receipt of United States (U.S.) regulatory approval from all government authorities required by the agreement and other closing conditions...